EP2076769

GENMAB A/S
Application Number
EP07817819A
Filing Date
Oct 2, 2007
Status
Granted And Under Opposition
Mar 23, 2018
Grant Date
Apr 25, 2018
External Links
Slate, Register

Biblio Summary

The patent EP2076769B1 was granted on Apr 25, 2018 by Genmab A/S The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MORPHOSYS AGJan 25, 2019WITHDRAWN

The table below shows the patents of Genmab A/S that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3319996Bispecific And Multispecific Antibodies And Method For Isolation Of SuchJan 3, 20242
EP2943507Inert FormatFeb 26, 20202
EP3312196Antibodies Against Cd38 For Treatment Of Multiple MyelomaJul 17, 20191

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.